UBS Group’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $143M | Buy |
624,180
+151,704
| +32% | +$27.5M | 0.02% | 890 |
|
|
2026
Q1 | $63M | Buy |
472,476
+270,554
| +134% | +$43.1M | 0.01% | 1409 |
|
|
2025
Q4 | $35M | Sell |
201,922
-402,012
| -67% | -$66.1M | 0.01% | 2012 |
|
|
2025
Q3 | $116M | Buy |
603,934
+460,372
| +321% | +$84.7M | 0.02% | 925 |
|
|
2025
Q2 | $42.8M | Sell |
143,562
-12,998
| -8% | -$4.08M | 0.01% | 1656 |
|
|
2025
Q1 | $51.6M | Sell |
156,560
-80,191
| -34% | -$24.2M | 0.01% | 1458 |
|
|
2024
Q4 | $68.9M | Buy |
236,751
+118,780
| +101% | +$36.7M | 0.01% | 1187 |
|
|
2024
Q3 | $40.6M | Sell |
117,971
-1,645
| -1% | -$543K | 0.01% | 1299 |
|
|
2024
Q2 | $35.6M | Buy |
119,616
+9,939
| +9% | +$3.37M | 0.01% | 1264 |
|
|
2024
Q1 | $45.1M | Buy |
109,677
+14,726
| +16% | +$5.71M | 0.01% | 1106 |
|
|
2023
Q4 | $34.3M | Buy |
94,951
+12,318
| +15% | +$4.34M | 0.01% | 1215 |
|
|
2023
Q3 | $27.1M | Buy |
82,633
+12,034
| +17% | +$3.79M | 0.01% | 1260 |
|
|
2023
Q2 | $21.3M | Buy |
70,599
+44,026
| +166% | +$12.7M | 0.01% | 1407 |
|
|
2023
Q1 | $7.11M | Sell |
26,573
-14,859
| -36% | -$4.27M | ﹤0.01% | 2188 |
|
|
2022
Q4 | $13.7M | Buy |
41,432
+4,267
| +11% | +$1.45M | 0.01% | 1686 |
|
|
2022
Q3 | $12.3M | Sell |
37,165
-26,200
| -41% | -$8.44M | 0.01% | 1629 |
|
|
2022
Q2 | $17.7M | Buy |
63,365
+26,834
| +73% | +$8.11M | 0.01% | 1401 |
|
|
2022
Q1 | $12.2M | Sell |
36,531
-22,596
| -38% | -$6.96M | ﹤0.01% | 1791 |
|
|
2021
Q4 | $18.8M | Buy |
59,127
+16,114
| +37% | +$4.79M | 0.01% | 1630 |
|
|
2021
Q3 | $11.7M | Buy |
43,013
+30,029
| +231% | +$7.93M | ﹤0.01% | 1914 |
|
|
2021
Q2 | $3.29M | Buy |
12,984
+1,147
| +10% | +$288K | ﹤0.01% | 3094 |
|
|
2021
Q1 | $2.77M | Sell |
11,837
-1,254
| -10% | -$280K | ﹤0.01% | 3220 |
|
|
2020
Q4 | $2.78M | Sell |
13,091
-64,634
| -83% | -$13.3M | ﹤0.01% | 3064 |
|
|
2020
Q3 | $14.2M | Sell |
77,725
-81,702
| -51% | -$14.9M | 0.01% | 1406 |
|
|
2020
Q2 | $28.4M | Buy |
159,427
+140,621
| +748% | +$23.9M | 0.01% | 881 |
|
|
2020
Q1 | $2.63M | Buy |
18,806
+8,293
| +79% | +$1.11M | ﹤0.01% | 2500 |
|
|
2019
Q4 | $1.43M | Buy |
10,513
+1,053
| +11% | +$133K | ﹤0.01% | 3878 |
|
|
2019
Q3 | $1.04M | Sell |
9,460
-2,319
| -20% | -$300K | ﹤0.01% | 3938 |
|
|
2019
Q2 | $1.69M | Sell |
11,779
-3,134
| -21% | -$429K | ﹤0.01% | 3302 |
|
|
2019
Q1 | $2.12M | Sell |
14,913
-18,742
| -56% | -$2.53M | ﹤0.01% | 2941 |
|
|
2018
Q4 | $3.91M | Buy |
33,655
+3,200
| +11% | +$419K | ﹤0.01% | 2386 |
|
|
2018
Q3 | $4.53M | Buy |
30,455
+1,788
| +6% | +$228K | ﹤0.01% | 2440 |
|
|
2018
Q2 | $2.81M | Sell |
28,667
-31,154
| -52% | -$2.72M | ﹤0.01% | 2846 |
|
|
2018
Q1 | $4.86M | Buy |
59,821
+49,595
| +485% | +$3.99M | ﹤0.01% | 2341 |
|
|
2017
Q4 | $784K | Sell |
10,226
-519
| -5% | -$37.5K | ﹤0.01% | 3970 |
|
|
2017
Q3 | $738K | Sell |
10,745
-19,321
| -64% | -$1.26M | ﹤0.01% | 3938 |
|
|
2017
Q2 | $2.08M | Buy |
30,066
+3,643
| +14% | +$224K | ﹤0.01% | 2976 |
|
|
2017
Q1 | $1.21M | Sell |
26,423
-18,506
| -41% | -$969K | ﹤0.01% | 3383 |
|
|
2016
Q4 | $2.44M | Buy |
44,929
+22,756
| +103% | +$1.24M | ﹤0.01% | 2740 |
|
|
2016
Q3 | $1.29M | Sell |
22,173
-6,347
| -22% | -$350K | ﹤0.01% | 3230 |
|
|
2016
Q2 | $1.42M | Sell |
28,520
-24,921
| -47% | -$1.33M | ﹤0.01% | 3068 |
|
|
2016
Q1 | $3.45M | Sell |
53,441
-9,829
| -16% | -$584K | ﹤0.01% | 2200 |
|
|
2015
Q4 | $3.8M | Sell |
63,270
-52,273
| -45% | -$3.29M | ﹤0.01% | 2205 |
|
|
2015
Q3 | $7.96M | Buy |
115,543
+62,422
| +118% | +$4.63M | 0.01% | 1563 |
|
|
2015
Q2 | $3.73M | Buy |
53,121
+14,935
| +39% | +$999K | ﹤0.01% | 2375 |
|
|
2015
Q1 | $2.57M | Buy |
38,186
+4,912
| +15% | +$284K | ﹤0.01% | 2702 |
|
|
2014
Q4 | $1.78M | Buy |
+33,274
| New | +$1.61M | ﹤0.01% | 3010 |
|
Other funds holding MOH
LIM
UBS Group's MOH Position: Q2 2026 in Review
UBS Group increased its Molina Healthcare (MOH) stake by 32% in Q2 2026, buying an estimated $27.5M and bringing the position to 624,180 shares worth $143M. The position accounts for 0.02% of the portfolio, ranked #890.
UBS Group first reported a position in MOH in Q4 2014 and has held it in 47 quarters since. 598 funds tracked by Wall St. Rank hold MOH as of Q2 2026.
- UBS Group held 624,180 shares of Molina Healthcare worth $143M as of Q2 2026.
- UBS Group bought 151,704 Molina Healthcare shares in Q2 2026, an estimated $27.5M.
- Molina Healthcare made up 0.02% of UBS Group's portfolio in Q2 2026, its #890 holding.
- UBS Group first reported a position in Molina Healthcare in Q4 2014 and has held it in 47 quarters since.
- 598 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.